# LAMIVUDINE
> **ANDA091475** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2023-10-06
## Drug
- **FDA Application Number:** ANDA091475
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **First approval:** 2023-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091475)
---
*AI Analytics · CC0 1.0*